Alerts will be sent to your verified email
Verify Email
PARNAXLAB
|
Parnax Lab
|
Natural Capsules
|
Accretion Nutraveda
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.65 % | 9.1 % | 77.09 % |
|
5yr average Equity Multiplier
|
2.74 | 1.91 | 7.25 |
|
5yr Average Asset Turnover Ratio
|
1.01 | 0.61 | 1.09 |
|
5yr Avg Net Profit Margin
|
4.21 % | 6.68 % | 14.14 % |
|
Price to Book
|
1.7 | 0.71 | 0.0 |
|
P/E
|
12.26 | 0.0 | 56.81 |
|
5yr Avg Cash Conversion Cycle
|
30.1 Days | 25.72 Days | 88.82 Days |
|
Inventory Days
|
45.64 Days | 27.47 Days | 125.44 Days |
|
Days Receivable
|
61.56 Days | 125.88 Days | 40.1 Days |
|
Days Payable
|
72.37 Days | 118.63 Days | 182.51 Days |
|
5yr Average Interest Coverage Ratio
|
2.99 | 7.96 | 5.76 |
|
5yr Avg ROCE
|
17.86 % | 10.02 % | 50.7 % |
|
5yr Avg Operating Profit Margin
|
13.13 % | 14.83 % | 23.04 % |
|
5 yr average Debt to Equity
|
1.12 | 0.51 | 3.41 |
|
5yr CAGR Net Profit
|
n/a | -38.15 % | 56.28 % |
|
5yr Average Return on Assets
|
4.42 % | 4.68 % | 16.23 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.3 % | 51.26 % | 73.48 % |
|
Share Pledged by Promoters
|
9.41 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -5.3 % | 73.48 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Parnax Lab
|
Natural Capsules
|
Accretion Nutraveda
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|